Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease
- PMID: 25635260
- PMCID: PMC4309524
- DOI: 10.1212/NXI.0000000000000063
Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease
Abstract
Objective: To show that immunotherapy with medications such mycophenolate mofetil (MMF) can cause serious complications in patients with neuromuscular disorders.
Methods: Two patients with neuromuscular disorders on immunotherapy with long-term MMF who developed toxoplasmic encephalitis (TE) were included in this case series.
Results: One patient with myasthenia gravis and one patient with inflammatory myopathy on immunotherapy with long-term MMF developed severe TE. Diagnosis was based on clinical presentation, MRI brain imaging characteristics, and CSF PCR positivity for Toxoplasma gondii. Both patients were treated with pyrimethamine, sulfadiazine, and leucovorin for 2 months without clinical improvement, and both died.
Conclusions: Immunotherapy with medications such as MMF can cause devastating TE in non-HIV patients with neuromuscular disorders. Early consideration and recognition of this complication is important to possibly prevent unfavorable outcomes. The utility of screening and prophylaxis against toxoplasmosis in individuals with neuroimmunologic disorders and other autoimmune disorders who receive immunosuppressive therapy requires future study.
Figures



Similar articles
-
CNS toxoplasmosis, a rare presentation in a patient with Myasthenia Gravis.IDCases. 2023 May 9;32:e01780. doi: 10.1016/j.idcr.2023.e01780. eCollection 2023. IDCases. 2023. PMID: 37229280 Free PMC article.
-
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.Antimicrob Agents Chemother. 2004 Dec;48(12):4848-54. doi: 10.1128/AAC.48.12.4848-4854.2004. Antimicrob Agents Chemother. 2004. PMID: 15561866 Free PMC article.
-
Toxoplasmic encephalitis in patients with AIDS.Infect Dis Clin North Am. 1988 Jun;2(2):429-45. Infect Dis Clin North Am. 1988. PMID: 3060527 Review.
-
Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs.J Vet Emerg Crit Care (San Antonio). 2009 Aug;19(4):369-74. doi: 10.1111/j.1476-4431.2009.00433.x. Epub 2009 Jul 28. J Vet Emerg Crit Care (San Antonio). 2009. PMID: 25164637
-
[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].Parassitologia. 2004 Jun;46(1-2):89-93. Parassitologia. 2004. PMID: 15305694 Review. Italian.
Cited by
-
Fulminant and Diffuse Cerebral Toxoplasmosis as the First Manifestation of HIV Infection: A Case Presentation and Review of the Literature.Am J Case Rep. 2020 Jan 26;21:e919624. doi: 10.12659/AJCR.919624. Am J Case Rep. 2020. PMID: 31982888 Free PMC article. Review.
-
Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls.Microbes Infect. 2016 Feb;18(2):153-8. doi: 10.1016/j.micinf.2015.09.023. Epub 2015 Oct 9. Microbes Infect. 2016. PMID: 26432947 Free PMC article.
-
Infectious Complications in Autoimmune Hemolytic Anemia.J Clin Med. 2021 Jan 5;10(1):164. doi: 10.3390/jcm10010164. J Clin Med. 2021. PMID: 33466516 Free PMC article. Review.
-
CNS toxoplasmosis, a rare presentation in a patient with Myasthenia Gravis.IDCases. 2023 May 9;32:e01780. doi: 10.1016/j.idcr.2023.e01780. eCollection 2023. IDCases. 2023. PMID: 37229280 Free PMC article.
-
Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii.PLoS Pathog. 2016 Feb 19;12(2):e1005447. doi: 10.1371/journal.ppat.1005447. eCollection 2016 Feb. PLoS Pathog. 2016. PMID: 26895155 Free PMC article.
References
-
- Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus 2005;14(suppl 1):s2–s8. - PubMed
-
- Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 2007;6:190–195. - PubMed
-
- Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996;15:389–393. - PubMed
-
- Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997;24:625–634. - PubMed
-
- Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002;29:691–698. - PubMed
LinkOut - more resources
Full Text Sources